Inocras, a bioinformatics-led company harnessing the power of whole genome data and proprietary analytics to deliver curated ...
BACKGROUND: Hypertension induces structural and functional damage in multiple organs. Evidence of subclinical damage ...
BCC Research examines how AI is improving diagnostic accuracy, enabling personalized treatments and optimizing therapeutic ...
On May 26, Pacific Biosciences of California, Inc. (NASDAQ:PACB) began global shipments of its SPRQ-Nx sequencing chemistry ...
The Danaher company expands its collaboration with AstraZeneca and Daiichi Sankyo to develop an end-to-end system for TROP2 ...
Mayo Clinic researchers and collaborators have shown that artificial intelligence can analyze routine pathology slides to ...
UNIGE's 3R Prize recognises an artificial intelligence tool that can predict metastasis risk while minimising the use of ...
Introduction Embryo aneuploidy increases substantially with maternal age, contributing to implantation failure and miscarriage. Conventional morphological assessment cannot determine euploidy.
The Rare Disease Genetic Testing Market is experiencing rapid expansion driven by technological innovations, increased awareness, and evolving healthcare policies worldwide. Advances in genomic ...
Abstract: Artificial intelligence has transformed healthcare through improved disease prediction and diagnostic accuracy. However, the prediction of osteoporosis remains challenging due to limitations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results